W. Michael Kavanaugh
Member of Scientific Advisory BoardDr. W. Michael Kavanaugh, also known as Mike, M.D., served as Member of Scientific Advisory Board at CytomX Therapeutics, Inc. since December 14, 2020. He has been IndependentDirector of AmMax Bio Inc. Dr. Kavanaugh serves as a Member of Scientific Advisory Board of Eureka Therapeutics, Inc. Dr. Kavanaugh served as a Member of Scientific Advisory Board at Estrella Biopharma Inc. until September 2025. Dr. Kavanaugh was Member of Scientific Advisory Board at CytomX Therapeutics, Inc. since December 1, 2020 until 2020 and served as its Chief Scientific Officer and Head of Research & Non-Clinical Development since January 5, 2015 until December 1, 2020 and served as its Senior Vice President until December 1, 2020. Dr. Kavanaugh joined CytomX Therapeutics, Inc. in 2015, Dr. Kavanaugh served multiple positions in research and development and led the growth of its therapeutic pipeline. He served as the Chief Scientific Officer and Senior Vice President at Five Prime Therapeutics, Inc. since January 2013 and served as its Senior Vice President of Preclinical Research. Before Five Prime, Dr. Kavanaugh served as vice president of Novartis Vaccines & Diagnostics, Inc. and executive director of Oncology Biologics in the Novartis Institutes of Biomedical Research. Dr. Kavanaugh served as Senior Vice President of Research and Preclinical Development at Five Prime Therapeutics, Inc. and served as its Senior Vice President of Research & Development. Dr. Kavanaugh has over two decades of experience in biologics. He served as Head of Biological Therapeutics, Emeryville Oncology, for the Novartis Institutes of Biomedical Research. He joined NIBR following several years at Chiron Corporation, where he advanced to Vice President and Head of Antibody and Protein Therapeutics Research. Dr. Kavanaugh is Board-Certified in Cardiovascular Disease and Internal Medicine and is Associate Clinical Professor of Medicine at the University of California at San Francisco. Dr. Kavanaugh serves as an attending staff physician at the San Francisco Veterans Administration Medical Center. Dr. Kavanaugh holds a BS in Molecular Biochemistry and Biophysics from Yale University, his M.D. degree from Vanderbilt University and trained in Internal Medicine, Cardiovascular Disease and Molecular and Cellular Biology at UCSF and the Cardiovascular Research Institute.
Positions
- Company NameCytomX Therapeutics, Inc.Stock CodeCTMXPositionMember of Scientific Advisory BoardColleagues
- SASean A. McCarthyChairman & CEO
- CWChristopher W. OgdenSVP, CFO & Secretary
- RLRachael LesterChief Business Officer & Senior VP
- MPMarcia P. BelvinSenior VP & Chief Scientific Officer
- AVAlejandra Veronica CarvajalChief Legal Officer
- MPMatthew P. YoungLead Independent Director
- JRJames R. MeyersIndependent Director
- HEHalley E. GilbertIndependent Director
